Urinary TIMP-2 and IGFBP7 are biomarkers recently approved by the Federal Drug Administration that successfully indicate future risk of AKI in hospitalized individuals [59,60,61], with the usefulness of these markers in predicting AKI in healthy individuals during heat stress only now beginning to be understood [62]. This evidence concerns the gene IGFBP7 and acute kidney injury.